Pharmaceutical company intelligence

SAFE PHARMACEUTICAL (PVT) LTD

Private pharmaceutical manufacturer · Karachi · Pakistan

Karachi pharmaceutical manufacturer operating since 2006 with a diversified portfolio covering major therapeutic categories.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.

Official website ↗ Official contact ↗

Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details

Latest regulatory-source observation23 Sep 2026Newest linked source record observed by MedInfoBase

Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio

Latest effective price date13 May 2026Newest effective date among published current price records

Corporate profile evidence5 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Location intelligence

Company location

Google Maps

Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗

Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view

Rx143public portfolio records represented

REG127unique registrations represented

IDX8indexed MedInfoBase presentations

SRC0additional source-observed presentations

R+0registry-only registrations

VER0registry-verified exact registrations

PKR136current validated price records

G53generic molecules in indexed catalogue

DF7dosage-form groups

TA11therapeutic areas

How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage95%

public portfolio presentations with a validated current price

Official-source coverage100%

products linked back to a source record

Unit-price parse coverage93%

priced packs safely normalized per unit

Comparable-market coverage85%

products with at least one like-for-like comparator

Therapeutic classification100%

products assigned to a broad therapeutic area

Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives77 products · 54%

CNS & mental health18 products · 13%

Pain & musculoskeletal14 products · 10%

Cardiovascular8 products · 6%

Gastrointestinal & hepatology8 products · 6%

Oncology & immunology7 products · 5%

Hematology & thrombosis3 products · 2%

Fluids & supportive care3 products · 2%

Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Third-generation cephalosporins19 products · 13%

Analgesics / NSAIDs12 products · 8%

Antimalarials10 products · 7%

Fluoroquinolone antibacterials9 products · 6%

Benzodiazepines / sedatives8 products · 6%

First-generation cephalosporins7 products · 5%

Oxazolidinone antibacterials7 products · 5%

Macrolide antibacterials6 products · 4%

Formulation footprint

Dosage forms

Injection55 products

Tablet45 products

Suspension19 products

Capsule14 products

Infusion6 products

Ointment2 products

Syrup2 products

How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales

#1 ZydulidLinezolid 7presentations 100 mg/5 mL, 200 mg/100 mL, 400 mg, 400 mg/200 mL · Suspension, Infusion, Tablet #2 DazDiazepam 6presentations 10 mg, 10 mg/2 mL, 5 mg · Tablet, Injection #3 NekrocinAmikacin 5presentations 100 mg/2 mL, 25 mg/2 mL, 250 mg, 50 mg/2 mL · Injection #4 OceclafCefotaxime 5presentations 0.25 g, 1 g, 1.0 g, 250 mg · Injection #5 TacrolimTacrolimus 5presentations 0.03 %, 0.1 %, 0.5 mg, 1 mg · Ointment, Capsule #6 TorlevaLevetiracetam 5presentations 1 g, 250 mg, 500 mg, 500 mg/5 mL · Tablet, Injection

Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis

Below market median11192% of comparable products

Near market median3within ±5% of median

Above market median76% of comparable products

Lowest-price equivalents19ties included

Company median price position -22.2% relative to the median unit price of like-for-like equivalent products.

Most competitively positioned examplesProducts with at least 3 market comparators

Fosfomycin 1 gFosfomycin · Injection · Vial PKR 57.04/vial/unit-68.1% vs market median Fasigyl 500 mgMetronidazole · IV infusion · 100ml PKR 0.90/mL-50.2% vs market median Bunex 0.2 mgBuprenorphine · Tablet · 50's PKR 12.01/tablet-43.3% vs market median Daz 10 mgDiazepam · Tablet · 1000's PKR 1.47/tablet-41.1% vs market median Daz 5 mgDiazepam · Tablet · 1000's PKR 0.83/tablet-39.0% vs market median

How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Mediate Pharmaceutical Pvt Ltd236 products · 90 generics 37shared generics Neutro Pharma (Pvt.) Ltd.,210 products · 97 generics 36shared generics M/s. Genix Pharma (Pvt) Ltd.297 products · 97 generics 33shared generics Pharmasol (Pvt) Ltd.257 products · 102 generics 33shared generics Zafa Pharmaceutical Laboratories (Pvt) Ltd.245 products · 97 generics 33shared generics Bosch Pharmaceuticals (Pvt) Ltd.258 products · 74 generics 32shared generics

Regulatory & price activity

Observed database signals

Indexed registration numbers127Distinct registrations among indexed, published, presentation-validated products only

Verified price observations143

Products with a verified price143

Products with multiple price observations0

Source records with multiple versions134

Latest portfolio source check22 Sep 2026

Latest effective price date13 May 2026

Latest source observation23 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

127 unique registration(s) · 8 indexed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Intelligence filter: Drug classBenzodiazepines / sedatives Clear intelligence filters

Brand	Generic	Strength	Form	Pack	Registration	Source-listed price	Unit price	Price position
Daz	Diazepam	10 mg/2 mL	Injection	2ml x 5's	053407	PKR 180.12	PKR 18.01/mL	Near median
Daz	Diazepam	10 mg/2 mL	Injection	2ml x 100's	053407	PKR 3,314.13	PKR 16.57/mL	15% below median
Daz	Diazepam	5 mg	Tablet	3 x 10's	057776	PKR 45.03	PKR 1.50/tablet	12% above median
Daz	Diazepam	5 mg	Tablet	1000's	057776	PKR 828.53	PKR 0.83/tablet	39% below median
Daz	Diazepam	10 mg	Tablet	3 x 10's	058449	PKR 75.05	PKR 2.50/tablet	11% above median
Daz	Diazepam	10 mg	Tablet	1000's	058449	PKR 1,472.45	PKR 1.47/tablet	41% below median
Hyrest	Midazolam	15 mg	Tablet	10's	090789	PKR 124.58	PKR 12.46/tablet	No comparator
Hyrest 7.5	Midazolam	7.5 mg	Tablet	1 x 10's Tablet	058246	PKR 75.05	PKR 7.51/tablet	34% below median

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record

MedInfoBase. (2026). SAFE PHARMACEUTICAL (PVT) LTD — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/company/safe-pharmaceutical-pvt-ltd/

Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.

SAFE PHARMACEUTICAL (PVT) LTD

What is sourced, and how recent is it?

Company profile

Company location

Portfolio at a glance

How complete is this profile?

Downloadable company intelligence charts

Therapeutic Portfolio Mix

Dosage Form Portfolio

Equivalent Price Position

Closest Portfolio Competitors

Therapeutic areas

Drug classes

Dosage forms

Deepest brand families

Unit-price positioning vs equivalent products

Portfolio overlap

Observed database signals

Medicine portfolio

Cite this record